S100A11 and intrahepatic cholangiocarcinoma: In tumors with a high expression of S100A11, such as in intrahepatic cholangiocarcinoma, the silencing of S100A11 can inhibit TGF-β1-induced cell migration, invasion, and epithelial-mesenchymal transition (EMT).